Month: May 2020

At the close of business on 13 May 2020, Morten Opstad, chair of the board of IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose of the extraordinary general meeting on 15 May 2020:Total 178,118,810 shares or 24.81% of the share capital and votes, consisting of the following:Proxy to represent and vote for 111,730,411 shares or 15.56% of the share capital, including shares held by Mr Opstad and close relations.Proxy with voting instructions for 66,388,399 shares or 9.25% of the share capital.For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.com   Tel: + 47 918 00186Derek D’Antilio, Chief financial OfficerE-mail: derek.dantilio@idexbiometrics.com   Tel: +1 197 827 31344About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider...

IMPORTANT NOTICE         By reading the following communication, you agree to be bound by the following limitations and qualifications:This communication is for informational purposes only and is not intended to and does not constitute an offer or invitation to exchange or sell or solicitation of an offer to subscribe for or buy, or an invitation to exchange, purchase or subscribe for, any securities, any part of the business or assets described herein, or any other interests or the solicitation of any vote or approval in any jurisdiction in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. This communication should not be construed in any manner as a recommendation to any reader of this document.This communication...

Strong fourth quarter and full year revenue growth and profitabilityCompany not providing guidance for fiscal 2021 at this time due to COVID-19DUBLIN, IRELAND, May 13, 2020 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 fourth quarter ended March 31, 2020.  Revenue as reported for the quarter increased 7% to $823.0 million compared with $768.2 million in the fourth quarter of fiscal 2019, with growth across all segments. Constant currency organic revenue (see Non-GAAP Financial Measures) growth was 8% for the fourth quarter of fiscal 2020.“We are pleased to end fiscal 2020 with such strong performance,” said Walt Rosebrough, President and Chief Executive Officer of STERIS. “We experienced modest financial impact from a decline in procedure volumes late...

BATON ROUGE, La., May 13, 2020 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at RBC Capital Markets 2020 Global Healthcare Conference on Tuesday, May 19, 2020.The presentation will begin at 1:20 p.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.About Amedisys:Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering...

LOS ANGELES, May 13, 2020 (GLOBE NEWSWIRE) — Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment and prevention of diseases, today announced that it will release its financial results for the first quarter ended March 31, 2020, after the market close on Thursday, May 14, 2020. Company management will host a conference call and webcast with slides to discuss its financial results and provide a general business update at 4:30 p.m. (ET) on the same day.About Capricor TherapeuticsCapricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment and prevention of diseases. Capricor’s...

MINNEAPOLIS, May 13, 2020 (GLOBE NEWSWIRE) — BBQ Holdings, Inc. (NASDAQ: BBQ) (the “Company”), an innovating global owner and operator of restaurants, today reported financial results for the first fiscal quarter ended March 29, 2020.  Note: The First Quarter results were affected by the COVID-19 pandemic as well as federal and state level mandates requiring stores to convert to To-go only business.First Quarter 2020 Highlights:Company-owned Famous Dave’s same store net sales decreased 6.8%.Prior to the closure of our dining rooms mid-March same store net sales increased 3.0%.Franchise-operated same store net sales decreased 13.1%.Prior to the closure of dining rooms, Famous Dave’s franchise-operated same store net sales decreased $2.0%.Same store To-go sales increased 8.4% at Company-owned Famous Dave’s restaurants.Closed the Granite...

AUSTIN, Texas, May 13, 2020 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that management will participate in the Bank of America Securities Virtual Healthcare Conference and the UBS Virtual Healthcare Conference.About Molecular Templates Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Molecular Templates’ proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like...

MONTREAL and SARASOTA, Fla., May 13, 2020 (GLOBE NEWSWIRE) — Intertape Polymer Group Inc. (TSX:ITP) (“IPG” or the “Company”) today announced the voting results from its annual meeting of shareholders (the “Meeting”) held on May 13, 2020.All nine nominees listed in its management information circular dated March 27, 2020 were elected as Directors of the Company at the Meeting. The results of the vote are set out below:The complete biographies of the elected Directors and further details about the Company’s corporate governance practices are available at www.itape.com.At the Meeting, Raymond Chabot Grant Thornton LLP was re-appointed as auditor of the Company.The shareholders adopted a resolution accepting, in an advisory, non-binding capacity, the Company’s approach to executive compensation disclosed under “Compensation of Executive...

LIVERMORE, Calif., May 13, 2020 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ: FORM), a leading semiconductor test and measurement supplier, announced that it has once again been named a 10 BEST and THE BEST Supplier in VLSIresearch’s annual customer satisfaction survey in three categories;10 BEST Focused Suppliers of Chip Making Equipment,THE BEST Suppliers of Test Equipment, andTHE BEST Suppliers of Test Subsystems.The survey includes the feedback of worldwide semiconductor manufacturing companies, rating suppliers in 14 categories, and measuring in each – supplier performance, customer service and product performance. The results mark seven consecutive years that FormFactor has been selected in THE BEST Suppliers of Test Subsystems which includes manufacturers of probe cards, test sockets and device interface boards. In April,...

TORONTO, May 13, 2020 (GLOBE NEWSWIRE) —All per share figures disclosed below are stated on a diluted basis.During the current quarter, the COVID-19 pandemic caused a series of events which led to significant disruptions in the global financial markets and economies.  Although the Company was not immune to the negative impact, its operating business segments have shown resiliency during this challenging period. The diversification of the Company’s businesses and revenue sources has helped to shield its Operating earnings from the full impact of the pandemic. The significant, rapid decline in the public equities markets towards the end of Q1 2020, especially its impact on the value of Bank of Montreal shares, posed the greatest stress to the Company’s financial position and results.  The write down in the fair value of the Securities...